FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula 
,
where R1 represents a carboxyl group or 3-methyl-1,2,4-oxadiazol-5-yl as a substitute: 
, R2 is an alkyl (C1-C5), cyclopropylmethyl, propargyl, 2,2,2-trifluoroethyl or ether substitute from the row:
, R3 represents: H, CH3.
EFFECT: novel low-molecular glucagon-like peptide-1 (GLP-1) receptor agonists are synthesized; the invention enables to expand the range of low-molecular GLP-1 receptor agonists.
19 cl, 9 dwg, 3 tbl, 82 ex
| Title | Year | Author | Number |
|---|---|---|---|
| (6S,9AS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]-4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETHYDIN-1-YL]PYRIDINE-2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRASINO[2,1-C][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND | 2014 |
|
RU2669805C2 |
| 1-(4-ISOXAZOLE-5-YL)-1H-PYRAZOLE-1-YL)-2-METHYLPROPANE-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATMENT OF AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION | 2018 |
|
RU2785342C2 |
| TREATMENT OF HELICOBACTER PYLORI INFECTIONS WITH USE OF MTAN INHIBITORS | 2015 |
|
RU2663803C2 |
| MULTIFUNCTIONAL QUINOLINE DERIVATIVES AS ANTINEURODEGENERATIVE AGENTS | 2013 |
|
RU2642466C2 |
| CRYSTAL (6S,9AS)-N-BENZYL-8-({6-[3-(4-ETHYLPIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN-2-YL}METHYL)-6-(2-FLUORINE-4-HYDROXYBENZYL)-4,7-DIOXO-2-(PROP-2-EN-1-YL)HEXAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE | 2016 |
|
RU2723551C2 |
| NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR TREATMENT OF MAMMALIAN INFECTIONS AND NEW METABOLIC MECHANISM | 2017 |
|
RU2752568C2 |
| NEW GLP-1 RECEPTOR MODULATORS | 2012 |
|
RU2634896C2 |
| INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
| 2-((1-(4R-BENZYL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)-3-METHYL-6-(PROP-1-en-2-YL)CYCLOHEX-3-en-1-ol AS ANTIPARKINSONIAN AGENT | 2023 |
|
RU2812081C1 |
| 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS ALK5 AND/OR ALK4 INHIBITORS | 2012 |
|
RU2612958C2 |
